Story excerpt provided by Dayton Business Journal.
Written by Tristan Navera.
Dr. Amol Soin is setting his sights on a new drug with immense potential for pain relief. It also has huge potential for helping to create the next billion-dollar company in the Dayton region.
Soin, who is head of Centerville-based Ohio Pain Clinic, is part of a team of physicians developing a drug that treats diabetic neuropathy pain. Soin and his team filed a patent last February and filed an Investigational New Drug Application with the U.S. Food and Drug Administration in December, paving the way for clinical tests to be done locally starting within a few months.
Click here to read the complete article.
Originally published February 4, 2015.